The use of hormonal growth factors in the treatment of patients with short-bowel syndrome

Drugs

Volumn 66, Issue 5, 2006, Pages 581-589

  Jeppesen, Palle B ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GLUCAGON LIKE PEPTIDE 2; GLUTAMINE; GROWTH HORMONE; HUMAN GROWTH HORMONE; ORAL REHYDRATION SOLUTION; RECOMBINANT GROWTH HORMONE; TEDUGLUTIDE; UNCLASSIFIED DRUG;

BODY WEIGHT; CARBOHYDRATE DIET; CLINICAL TRIAL; COLON; CREATININE URINE LEVEL; DRUG EFFECT; DRUG MEGADOSE; DRUG SAFETY; EDEMA; ENERGY ABSORPTION; GENERALIZED EDEMA; HUMAN; INTESTINE ABSORPTION; INTESTINE RESECTION; JEJUNOSTOMY; LEAN BODY WEIGHT; LONG TERM CARE; LOW DRUG DOSE; LOW FAT DIET; NONHUMAN; PARENTERAL NUTRITION; PELVIC FLOOR MUSCLE TRAINING; PERIPHERAL EDEMA; REVIEW; SHORT BOWEL SYNDROME; SIDE EFFECT; TREATMENT WITHDRAWAL; WEIGHT CHANGE; WEIGHT GAIN; WEIGHT REDUCTION;

BODY COMPOSITION; BODY WEIGHT; CREATININE; DRUG MONITORING; ENERGY INTAKE; GLUCAGON-LIKE PEPTIDE 2; GLUCAGON-LIKE PEPTIDES; GLUTAMINE; GROWTH HORMONE; HUMANS; HYPERPLASIA; INTESTINAL ABSORPTION; INTESTINES; PEPTIDES; RANDOMIZED CONTROLLED TRIALS; SHORT BOWEL SYNDROME; TIME FACTORS;

EID: 33646367422     PISSN: 00126667     EISSN: 00126667     Source Type: Journal    
DOI: 10.2165/00003495-200666050-00001     Document Type: Review

References (50)

1. Nightingale JM, Lennard-Jones JE. The short bowel syndrome: what's new and old? Dig Dis 1993; 11: 12-31
2. Nightingale JM, Lennard Jones JE, Walker ER, et al. Jejunal efflux in short bowel syndrome. Lancet 1990; 336 (8718): 765-8
3. Nightingale JM, Lennard Jones JE, Gertner DJ, et al. Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gall stones in patients with a short bowel. Gut 1992; 33 (11): 1493-7
4. JMD Nightingale, editor. Intestinal failure. London: Greenwich Medical Media Limited, 2001
5. Jeppesen PB, Mortensen PB. Intestinal failure defined by measurements of intestinal energy and wet weight absorption. Gut 2000; 46 (5): 701-6
6. Jeppesen PB. Intestinal insufficiency and failure. Dan Med Bull 2003; 50 (3): 238-61
7. Forrester JM. The number of villi in rat's jejunum and ileum: effect of normal growth, partial enterectomy, and tube feeding. J Anat 1972; 111 (2): 283-91
8. Friedman HI, Chandler JG, Peck CC, et al. Alterations in intestinal structure, fat absorption and body weight after intestinal bypass for morbid obesity. Surg Gynecol Obstet 1978; 146 (5): 757-67
9. O'Keefe SJ, Haymond MW, Bennet WM, et al. Long-acting somatostatin analogue therapy and protein metabolism in patients with jejunostomies. Gastroenterology 1994; 107: 379-88
10. Ziegler TR, Fernandez-Estivariz C, Gu LH, et al. Distribution of the H+/peptide transporter PepT1 in human intestine: up-regulated expression in the colonic mucosa of patients with short-bowel syndrome. Am J Clin Nutr 2002; 75: 379-88
11. Eastwood GL. Gastrointestinal epithelial renewal. Gastroenterology 1977; 72 (5 Pt 1): 962-75
12. Dowling RH, Booth CC. Structural and functional changes following small intestinal resection in the rat. Clin Sci 1967; 32 (1): 139-49
13. Obertop H, Nundy S, Malamud D, et al. Onset of cell proliferation in the shortened gut: rapid hyperplasia after jejunal resection. Gastroenterology 1977; 72 (2): 267-70
14. Nygaard K. Resection of the small intestine in rats: 3. Morphological changes in the intestinal tract. Acta Chir Scand 1967; 133 (3): 233-48
15. Booth CC, Evans KT, Menzies T, et al. Intestinal hypertrophy following partial resection of the small bowel in the rat. Br J Surg 1958; 46: 403-10
16. Porus RL. Epithelial hyperplasia following massive small bowel resection in man. Gastroenterology 1965; 48 (6): 753-7
17. Hanson WR, Osborne JW, Sharp JG. Compensation by the residual intestine after intestinal resection in the rat: I. influence of amount of tissue removed. Gastroenterology 1977; 72 (4 Pt 1): 692-700
18. Hanson WR, Osborne JW, Sharp JG. Compensation by the residual intestine after intestinal resection in the rat: II. Influence of postoperative time interval. Gastroenterology 1977; 72 (4 Pt 1): 701-5
19. Tilson MD, Wright HK. Adaptation of functioning and by-passed segments of ileum during compensatory hypertrophy of the gut. Surgery 1970; 67 (4): 687-93
20. Weser E, Hernandez MH. Studies of small bowel adaptation after intestinal resection in the rat. Gastroenterology 1971; 60 (1): 69-75
21. Tilson MD, Michaud JT, Livstone EM. Early proliferative activity in the left colon of the rat after partial small-bowel resection. Surg Forum 1976; 27 (62): 445-6
22. Williamson RC, Bauer FL, Ross JS, et al. Proximal enterectomy stimulates distal hyperplasia more than bypass or pancreaticobiliary diversion. Gastroenterology 1978; 74 (1): 16-23
23. Nundy S, Malamud D, Obertop H, et al. Onset of cell proliferation in the shortened gut. Colonic hyperplasia after ileal resection. Gastroenterology 1977; 72 (2): 263-6
24. Solhaug JH, Tvete S. Adaptative changes in the small intestine following bypass operation for obesity: a radioglocal and histological study. Scand J Gastroenterol 1978; 13 (4): 401-8
25. Young EA, Weser E. Nutritional adaptation after small bowel resection in rats. J Nutr 1974; 104 (8): 994-1001
26. Wright HK, Poskitt T, Cleveland JC, et al. The effect of total colectomy on morphology and absorptive capacity of ileum in the rat. J Surg Res 1969; 9 (5): 301-4
27. Woo ZH, Nygaard K. Small-bowel adaptation after colectomy in rats. Scand J Gastroenterol 1978; 13 (8): 903-10
28. Nightingale JM, Lennard Jones JE. The short bowel syndrome: what's new and old? Dig Dis 1993; 11 (1): 12-31
29. Dowling RH, Booth CC. Functional compensation after small-bowel resection in man. Demonstration by direct measurement. Lancet 1966; II (7455): 146-7
30. Weinstein LD, Shoemaker CP, Hersh T, et al. Enhanced intestinal absorption after small bowel resection in man. Arch Surg 1969; 99 (5): 560-2
31. Hill GL, Mair WS, Goligher JC. Impairment of 'ileostomy adaptation' in patients after ileal resection. Gut 1974; 15 (12): 982-7
32. Gouttebel MC, Saint Aubert B, Colette C, et al. Intestinal adaptation in patients with short bowel syndrome: measurement by calcium absorption. Dig Dis Sci 1989; 34 (5): 709-15
33. McCarthy DM, Kim YS. Changes in sucrase, enterokinase, and peptide hydrolase after intestinal resection: the association of cellular hyperplasia and adaptation. J Clin Invest 1973; 52 (4): 942-51
34. Tilson MD, Wright HK. An adaptive change in ileal Na-K-ATPase activity after jejunectomy or jejunal transposition. Surgery 1971; 70 (3): 421-4
35. Remington M, Malagelada JR, Zinsmeister A, et al. Abnormalities in gastrointestinal motor activity in patients with short bowels: effect of a synthetic opiate. Gastroenterology 1983; 85 (3): 629-36
36. Byrne TA, Morrissey TB, Nattakom TV, et al. Growth hormone, glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome. JPEN J Parenter Enteral Nutr 1995; 19 (4): 296-302
37. Scolapio JS, Camilleri M, Fleming CR, et al. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology 1997; 113 (4): 1074-81
38. Szkudlarek J, Jeppesen PB, Mortensen PB. Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomised, double blind, crossover, placebo controlled study. Gut 2000; 47 (2): 199-205
39. Jeppesen PB, Szkudlarek J, Hoy CE, et al. Effect of high-dose growth hormone and glutamine on body composition, urine creatinine excretion, fatty acid absorption, and essential fatty acids status in short bowel patients: a randomized, double-blind, crossover, placebo-controlled study. Scand J Gastroenterol 2001; 36 (1): 48-54
40. Byrne TA, Wilmore DW, Iyer K, et al. Growth hormone, glutamine, and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome. Ann Surg 2005; 242: 655-61
41. Seguy D, Vahedi K, Kapel N, et al. Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study. Gastroenterology 2003; 124 (2): 293-302
42. Ellegard L, Bosaeus I, Nordgren S, et al. Low-dose recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome. Ann Surg 1997; 225 (1): 88-96
43. Jeppesen PB, Hartmann B, Thulesen J, et al. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology 2001; 120 (4): 806-15
44. Jeppesen PB, Sanguinetti EL, Buchman A, et al. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagons-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut 2005; 54: 1224-31
45. Byrne TA, Persinger RL, Young LS, et al. A new treatment for patients with short-bowel syndrome: growth hormone, glutamine, and a modified diet. Ann Surg 1995; 222 (3): 243-54
46. Johannsson G, Sverrisdottir YB, Ellegard L, et al. GH increases extracellular volume by stimulating sodium reabsorption in the distal nephron and preventing pressure natriuresis. J Clin Endocrinol Metab 2002; 87 (4): 1743-9
47. Scolapio JS. Effect of growth hormone, glutamine, and diet on body composition in short bowel syndrome: a randomized, controlled study. JPEN J Parenter Enteral Nutr 1999; 23 (6): 309-13
48. Jeppesen PB, Langholz E, Mortensen PB. Quality of life in patients receiving home parenteral nutrition. Gut 1999; 44 (6): 844-52
49. Drucker DJ, Shi Q, Crivici A, et al. Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV. Nat Biotechnol 1997; 15 (7): 673-7
50. Thulesen J, Hartmann B, Hare KJ, et al. Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice. Gut 2004; 53: 1145-50